Physician profile

Sripal Bangalore

Interventional Cardiology · New York, NY

NPI 1902066871

$481,580.43

in general payments reported to CMS, 2019-2025

26 companies · $127K in 2025

The $127K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$218,381.86
Travel and Lodging$75,697.48
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$65,376.00
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program$12,650.00
Food and Beverage$12,249.38
Honoraria$2,000.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Mylan INC. $194,901.30 2022-2025 Norvasc
Abbott Laboratories $59,976.24 2019-2025 Dragonfly Opstar, Optis, Pressurewire
Inari Medical, INC. $38,926.43 2021-2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Imperative Care, INC $29,508.03 2023-2025 Zoom 88-T Large Distal Platform, Symphony Catheter
Angiodynamics, INC. $28,774.55 2019-2025 Alphavac, Angiovac, Auryon Laser System 100-120 Vac
Boston Scientific Corporation $20,321.74 2021-2025 General - Structural Heart, Avvigo Guidance System, Rotapro
Stryker Corporation $17,911.64 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever
Amgen INC. $16,403.44 2019-2021
Shockwave Medical, INC $13,821.15 2021-2024 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Truvic Medical, INC. $13,107.47 2022
Biotronik INC. $12,318.53 2019-2023
Boehringer Ingelheim Mena (Scientific Office) Fz-LLC $12,265.80 2021
Recor Medical INC $10,568.25 2025 Paradise Ultrasound Renal Denervation System
Pfizer INC. $3,500.00 2019
Merck Sharp & Dohme LLC $3,355.00 2022
Show all 25 companies
CompanyGeneral paymentsYearsTop products
Magenta Medical INC $2,250.00 2023-2024
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $2,000.00 2025 Lifevest
Argon Medical Devices, INC. $645.47 2022-2024 Cleaner, Clot Management
Terumo Medical Corporation $350.00 2022
Medtronic, INC. $240.64 2022-2023 Onyx Frontier, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan
Zoll Circulation INC $239.00 2024 Catheter, Therox Ds2 Console, Downstream Cartridge
Abiomed $64.24 2025
Cardiva Medical, INC. $63.13 2025 Cardiva Vascade Mvp Vvcs 6-12f
W. L. Gore & Associates, INC. $34.40 2025 Gore Cardioform Septal Occluder
Siemens Medical Solutions USA, INC. $33.98 2022

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sripal Bangalore

$481,580.43

in general payments reported 2019-2025

Years
2019-2025
Top company
Mylan INC.
Context
The $127K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/131013/sripal-bangalore

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.